Cargando…
Cancer Stem Cells: Powerful Targets to Improve Current Anticancer Therapeutics
A frequent observation in several malignancies is the development of resistance to therapy that results in frequent tumor relapse and metastasis. Much of the tumor resistance phenotype comes from its heterogeneity that halts the ability of therapeutic agents to eliminate all cancer cells effectively...
Autores principales: | Bighetti-Trevisan, Rayana L., Sousa, Lucas O., Castilho, Rogerio M., Almeida, Luciana O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6874936/ https://www.ncbi.nlm.nih.gov/pubmed/31781251 http://dx.doi.org/10.1155/2019/9618065 |
Ejemplares similares
-
Identification of CD114 Membrane Receptors as a Molecular Target in Medulloblastomas
por: Monteiro, Jander Moreira, et al.
Publicado: (2023) -
Effect of Mesenchymal Stem Cells Overexpressing BMP-9 Primed with Hypoxia on BMP Targets, Osteoblast Differentiation and Bone Repair
por: Paz, Jessica Emanuella Rocha Moura, et al.
Publicado: (2023) -
Profiling the Behavior of Distinct Populations of Head and Neck Cancer Stem Cells
por: Almeida, Luciana O., et al.
Publicado: (2016) -
Epigenetic Modifications and Head and Neck Cancer: Implications for Tumor Progression and Resistance to Therapy
por: Castilho, Rogerio M., et al.
Publicado: (2017) -
Sensitizing mucoepidermoid carcinomas to chemotherapy by targeted disruption of cancer stem cells
por: Guimarães, Douglas M., et al.
Publicado: (2016)